v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Income Statement [Abstract]        
INCOME FROM EQUITY METHOD INVESTMENT - LAB SERVICES MSO $ 392,677 $ 392,677 $ (846,588)
OTHER OPERATING EXPENSES:        
Advertising and marketing expenses 209,846 71,150 843,497 237,671
Professional fees 1,581,951 1,632,215 5,254,207 1,590,268
Compensation and related benefits 223,416 309,022 1,101,574 1,308,854
Amortization of intangible assets 563,000 2,158,167  
Other general and administrative expenses 142,913 165,713 784,758 857,869
Total Other Operating Expenses 2,721,126 2,178,100 7,984,036 3,994,662
LOSS FROM OPERATIONS (2,721,126) (1,785,423) (7,591,359) (4,841,250)
OTHER (EXPENSE) INCOME        
Interest expense - amortization of debt discount and debt issuance costs (189,417) (283,755) (1,136,412) (1,291,814)
Interest expense - other (82,029) (81,956) (320,282) (325,486)
Interest expense - related party     (42,445)
Debt modification charge     (838,794)
Change in fair value of derivative liability (1,276,889) (114,360) 538,213 374,365
Loss on extinguishment of debt     (9,076,587)
Other income (expense) (107,219) (1,186) 67,554 (74,180)
Total Other Expense (1,655,554) (481,257) (9,927,514) (2,198,354)
LOSS BEFORE INCOME TAXES (4,376,680) (2,266,680) (17,518,873) (7,039,604)
INCOME TAXES
NET LOSS FROM CONTINUING OPERATIONS (4,376,680) (2,266,680) (17,518,873) (7,039,604)
NET LOSS FROM DISCONTINUED OPERATIONS (103,015) (215,431) (742,103) (863,790)
NET LOSS (4,479,695) (2,482,111) (18,260,976) (7,903,394)
LESS: NET LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST
NET LOSS AFTER NONCONTROLLING INTEREST (4,479,695) (2,482,111) (18,260,976) (7,903,394)
DEEMED CONTRIBUTION ON EXCHANGE OF EQUITY INSTRUMENTS 162,473 162,473
NET LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (4,479,695) $ (2,319,638) $ (18,098,503) $ (7,903,394)
NET LOSS PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:        
Basic, continuing operations (in Dollars per share) $ (0.49) $ (1.3) $ (5.41) $ (7.52)
Diluted, continuing operations (in Dollars per share) (0.49) (1.3) (5.41) (7.52)
Basic, discontinued operations (in Dollars per share) (0.01) (0.13) (0.23) (0.92)
Diluted, discontinued operations (in Dollars per share) (0.01) (0.13) (0.23) (0.92)
Basic (in Dollars per share) (0.5) (1.43) (5.64) (8.44)
Diluted (in Dollars per share) $ (0.5) $ (1.43) $ (5.64) $ (8.44)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:        
Basic (in Shares) 8,963,998 1,624,629 3,210,779 936,614
Diluted (in Shares) 8,963,998 1,624,629 3,210,779 936,614
COMPREHENSIVE LOSS:        
NET LOSS $ (4,479,695) $ (2,482,111) $ (18,260,976) $ (7,903,394)
OTHER COMPREHENSIVE LOSS FROM CONTINUED OPERATIONS        
Unrealized foreign currency translation (loss) gain (311) 279 (9,402) (273)
COMPREHENSIVE LOSS (4,480,006) (2,481,832) (18,270,378) (7,903,667)
LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NONCONTROLLING INTEREST
COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (4,480,006) $ (2,481,832) $ (18,270,378) $ (7,903,667)